The growing focus on precision medicine is strengthening interest in gene therapy as a promising therapeutic approach. With continued advances in genetic research, treatment technologies, and clinical development, the Gene Therapy Market is becoming an increasingly important area within the healthcare industry.

The global Gene Therapy Market is witnessing strong expansion as advancements in genetic engineering, growing prevalence of genetic and chronic diseases, supportive regulatory frameworks, and increasing research and development investments strengthen the adoption of gene therapy solutions. The Gene Therapy Market was valued at US$ 5.06 billion in 2024 and is projected to reach US$ 12.92 billion by 2031, registering a CAGR of 14.50% during 2025 to 2031. The market reflects increasing interest in innovative therapeutic approaches designed to address diseases at the genetic level. The Gene Therapy Market is developing across multiple therapeutic applications, delivery approaches, and vector technologies. Gene therapy involves manipulating genes to treat or prevent diseases by inactivating a faulty gene, replacing it with a healthy copy, or introducing a new or modified gene. The approach includes in vivo and ex vivo therapies and is being applied across cancer, neurological diseases, cardiovascular disease, infectious diseases, and rare diseases.

Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00004544

Gene Therapy Market Size and Growth Outlook

The Gene Therapy Market size represents a rapidly expanding area within the healthcare and life sciences industry. From US$ 5.06 billion in 2024, the market is expected to reach US$ 12.92 billion by 2031. This growth represents increasing demand for advanced therapies capable of addressing genetic causes and complex diseases. The market is expected to register a CAGR of 14.50% from 2025 to 2031, highlighting significant growth potential throughout the forecast period.

The increasing prevalence of genetic diseases and cancer is an important factor supporting the Gene Therapy Market size. In addition, continued advancements in genetic engineering technologies are expanding the potential applications of gene therapy. Technologies such as CRISPR/Cas9, base editing, and enhanced viral vectors are supporting the development and application of innovative therapies.

Key Factors Driving the Gene Therapy Market

Several factors are contributing to the expansion of the Gene Therapy Market. The growing prevalence of genetic diseases and cancer is increasing the need for advanced treatment approaches. In the US, approximately 25 to 30 million individuals suffer from rare diseases, many of which are genetic and suitable for gene therapy.

Technological advancement is another major growth factor. Innovations in genetic engineering, including CRISPR/Cas9, base editing, and improved viral vectors, are accelerating the development of gene therapy applications. Increasing research and development investments are also strengthening the industry, with public-private partnerships and grants supporting thousands of clinical trials worldwide.

Supportive government initiatives and regulatory developments further contribute to market expansion. The report identifies regulatory efforts focused on accelerating the approval process for cell and gene therapies while maintaining ongoing monitoring. Expansion of healthcare infrastructure and increasing investment in research are also creating opportunities for companies operating in this field.

Gene Therapy Market Segmentation

The Gene Therapy Market is segmented by vectors, indication, delivery mode, and geography. By vectors, the market includes non-viral vectors and viral vectors. Viral vectors accounted for the largest share in 2024, representing 84.2% of the market. Viral vectors include adeno-associated viruses, lentiviruses, adenoviruses, and retroviruses.

By indication, the market covers neurological diseases, cancer, Duchenne muscular dystrophy, hepatological diseases, and other indications. Cancer is anticipated to witness the fastest growth, with a CAGR of 15% during the forecast period. The rising prevalence of cancer and increasing demand for targeted treatment approaches are contributing to this growth.

By delivery mode, the Gene Therapy Market is divided into in vivo and ex vivo. The ex vivo segment accounted for the largest share in 2024, representing 58.7% of the market. These segmentation categories provide a detailed understanding of the market structure and the areas contributing to overall Gene Therapy Market growth.

Regional Outlook of the Gene Therapy Market

North America dominated the Gene Therapy Market in 2024 with a 46.3% market share. The region benefits from increasing research and development activities, technological innovation, and the adoption of advanced gene editing approaches. The United States market is projected to register a CAGR of 14.4% during the forecast period.

Asia Pacific represents another important growth area and is projected to register the fastest growth, with a CAGR of 17.2% during the forecast period. Supportive research infrastructure, government regulations, increasing disease burden, and business expansion strategies are contributing to regional market development.

Europe also represents a substantial portion of the market, supported by the adoption of CRISPR/Cas9, base editing, improved viral vector technologies, and advanced research infrastructure. South and Central America, along with the Middle East and Africa, are also experiencing opportunities supported by healthcare infrastructure investments, government initiatives, clinical research, and partnerships.

Emerging Opportunities in the Gene Therapy Market

Expansion into emerging markets represents an important opportunity for the Gene Therapy Market. Increasing accessibility to gene editing technologies and gene delivery systems can support the development of treatments for unmet medical needs. Personalized medicine is another opportunity, as treatments can be customized according to different genetic profiles.

Research and development activities by market participants are also creating opportunities for improved gene therapy techniques. Areas such as non-viral delivery methods, improved safety profiles, and enhanced patient outcomes are receiving attention. Emerging applications in autoimmune diseases and solid tumors may further support market development.

The expansion of gene therapy contract development and manufacturing organizations also creates opportunities across the industry. Collaboration between manufacturers and CDMOs can support the development and production of therapies using advanced genetic engineering tools.

Top Key Players in the Gene Therapy Market

The Gene Therapy Market includes several established pharmaceutical, biotechnology, and life sciences companies. Top key players profiled in the report include Novartis AG, Astellas Pharma Inc, Bristol-Myers Squibb Co, Bluebird Bio Inc, Catalent Inc, Sanofi SA, Daiichi Sankyo Co Ltd, CSL Behring LLC, BioMarin Pharmaceutical Inc., and Vertex Pharmaceuticals Inc.

Additional companies analyzed include Intellia Therapeutics, Sana Biotechnology, Caribou Biosciences, Editas Medicine, Beam Therapeutics, Sangamo Therapeutics, Freeline, Orchard Therapeutics, uniQure, Pfizer, Takara Bio Inc, PTC Therapeutics, Adaptimmune Therapeutics, Adverum Biotechnologies, Bayer, and eGenesis.

Future Outlook for the Gene Therapy Market

The Gene Therapy Market outlook remains positive as technological advancements, increasing research activities, genetic disease prevalence, and supportive regulatory initiatives continue to influence industry development. The expansion of personalized medicine and advanced gene editing technologies is expected to create additional opportunities for market participants.

With the Gene Therapy Market projected to increase from US$ 5.06 billion in 2024 to US$ 12.92 billion by 2031 at a CAGR of 14.50% during 2025 to 2031, the market is positioned for substantial expansion. Continued investment in research, innovative delivery technologies, emerging applications, and regional healthcare infrastructure is expected to remain important to the market's development.

Trending Reports:

·         Gene Therapy Market Trends and Growth Insights 2025–2031

·         Epigenetics Market Growth, Share & Forecast 2031

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.

Contact Us:
Contact Person: Ankit Mathur 
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876

Also Available in: Korean|German|Japanese|French|Chinese|Italian|Spanish